Recombinant antibodies, such as single domain antibodies (sdAb), are a new generation of engineered antibody fragment that consist of a single monomeric variable antibody domain. sdAb is smaller, more soluble, and has higher stabilities than conventional antibodies. sdAb also features higher permeability, lower immunogenicity, and both simple and cost-effective production procedures. Based on Synbio Technologies’ extensive expertise in sdAb and advanced sdAb discovery technology, we can provide our customers with a comprehensive one stop solution from antigen production to specific recombinant sdAb expression.
Competitive Advantages
- Experienced antibody production team
- Proprietary Universal AntigenTM immunization technology
- Robust phage-display technology platform
- Advanced yeast-display technology platform (Large library capacity: ~ 109)
- Cost effective and milestone payment scheme
Service Specifications
| Milstones | Standard Deliverables | Turnaround Time (Business Days) |
|---|---|---|
| Camel immunization (eg. dromedaries, camels, llamas, and alpacas) |
|
10-11 Months |
| PBMC isolation & immune library construction | ||
| Screening of phage-displayed library | ||
| Functional assay for sdAb | ||
| Large scale sdAb expression by yeast (followed by properties identification) |
Standard Process
